Antimicrobial Resistance of Escherichia coli for Uncomplicated Cystitis: Korean Antimicrobial Resistance Monitoring System · Yu SH, Jung SI, Lee SJ et al.

References

  1. Flores-MirelesA.L. WalkerJ.N. CaparonM. HultgrenS.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment optionsNat. Rev. Microbiol.20151326928410.1038/nrmicro343225853778PMC4457377
  2. FoxmanB. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burdenInfect. Dis. Clin. N. Am.20142811310.1016/j.idc.2013.09.00324484571
  3. HootonT.M. Clinical practice. Uncomplicated urinary tract infectionN. Engl. J. Med.20123661028103710.1056/NEJMcp110442922417256
  4. BonkatG. BruyèreR.B.F. CaiT. GeerlingsS.E. KövesB. KranzJ. SchubertS. PilatzA. VeeratterapillayR. WagenlehnerF. EAU Guidelines on Urological InfectionsEur. Assoc. Urol.202418222610.1016/j.eururo.2024.03.03538714379
  5. FoxmanB. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costsDis. Mon.200349537010.1067/mda.2003.712601337
  6. WagenlehnerF.M. HoymeU. KaaseM. FunfstuckR. NaberK.G. SchmiemannG. Uncomplicated urinary tract infectionsDtsch. Aerzteblatt Online201110841542310.3238/arztebl.2011.041521776311PMC3132618
  7. AngerJ. LeeU. AckermanA.L. ChouR. ChughtaiB. ClemensJ.Q. HicklingD. KapoorA. KentonK.S. KaufmanM.R. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU GuidelineJ. Urol.201920228228910.1097/JU.000000000000029631042112
  8. NaberK.G. Tiran-SaucedoJ. WagenlehnerF.M.E. GroupR. Psychosocial burden of recurrent uncomplicated urinary tract infectionsGMS Infect. Dis.202210Doc0110.3205/id00007835463815PMC9006425
  9. ZhouY. ZhouZ. ZhengL. GongZ. LiY. JinY. HuangY. ChiM. Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment OptionsInt. J. Mol. Sci.2023241053710.3390/ijms24131053737445714PMC10341809
  10. WhelanS. LuceyB. FinnK. Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective TreatmentMicroorganisms202311216910.3390/microorganisms1109216937764013PMC10537683
  11. AlghamdiS.A.A. MirS.S. AlghamdiF.S. Al BanghaliM. AlmalkiS.S.R. Evaluation of Extended-Spectrum Beta-Lactamase Resistance in Uropathogenic Escherichia coli Isolates from Urinary Tract Infection Patients in Al-Baha, Saudi ArabiaMicroorganisms202311282010.3390/microorganisms1112282038137964PMC10745543
  12. AdedejiW.A. The Treasure Called AntibioticsAnn. Ib. Postgrad. Med.201614565728337088PMC5354621
  13. NathanC. Antibiotics at the crossroadsNature200443189990210.1038/431899a15496893
  14. LingW. Furuya-KanamoriL. EzureY. HarrisP.N.A. PatersonD.L. Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): A systematic review and meta-analysisJAC Antimicrob. Resist.20213dlab06810.1093/jacamr/dlab06835233528PMC8210200
  15. AslamB. WangW. ArshadM.I. KhurshidM. MuzammilS. RasoolM.H. NisarM.A. AlviR.F. AslamM.A. QamarM.U. Antibiotic resistance: A rundown of a global crisisInfect. Drug Resist.2018111645165810.2147/IDR.S17386730349322PMC6188119
  16. CekM. TandogduZ. WagenlehnerF. TenkeP. NaberK. Bjerklund-JohansenT.E. Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: Results from the GPIU studies 2003–2010World J. Urol.2014321587159410.1007/s00345-013-1218-924452449
  17. JerniganJ.A. HatfieldK.M. WolfordH. NelsonR.E. OlubajoB. ReddyS.C. McCarthyN. PaulP. McDonaldL.C. KallenA. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017N. Engl. J. Med.20203821309131910.1056/NEJMoa191443332242356PMC10961699
  18. MichaelC.A. Dominey-HowesD. LabbateM. The antimicrobial resistance crisis: Causes, consequences, and managementFront. Public Health2014214510.3389/fpubh.2014.0014525279369PMC4165128
  19. SpellbergB. SrinivasanA. ChambersH.F. New Societal Approaches to Empowering Antibiotic StewardshipJAMA20163151229123010.1001/jama.2016.134626914942PMC5611826
  20. WagenlehnerF. TandogduZ. BartolettiR. CaiT. CekM. KulchavenyaE. KovesB. NaberK. PerepanovaT. TenkeP. The Global Prevalence of Infections in Urology (GPUI) Study: A Worldwide Surveillance Study in Urology PatientsEur. Urol. Focus2016234534710.1016/j.euf.2016.03.00428723463
  21. LeeS.J. LeeD.S. ChoeH.S. ShimB.S. KimC.S. KimM.E. ChoY.H. Antimicrobial resistance in community-acquired urinary tract infections: Results from the Korean Antimicrobial Resistance Monitoring SystemJ. Infect. Chemother.20111744044610.1007/s10156-011-0248-821140281
  22. WadaK. TsuboiI. TakahashiS. YasudaM. MiyazakiJ. KobayashiK. MatsumotoM. HayamiH. YamamotoS. KiyotaH. Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticusJ. Infect. Chemother.20243027728510.1016/j.jiac.2024.01.01138242285
  23. KaraA. MassaroC. GiammancoG.M. AlduinaR. BoussoualimN. Phylogenetic Diversity, Antibiotic Resistance, and Virulence of Escherichia coli Strains from Urinary Tract Infections in AlgeriaAntibiotics20241377310.3390/antibiotics1308077339200073PMC11350822
  24. KotB. Antibiotic Resistance Among Uropathogenic Escherichia coliPol. J. Microbiol.20196840341510.33073/pjm-2019-04831880885PMC7260639
  25. ChoiU. KimE. LyuD.H. KimK.S. ParkB.H. ChungH. HanC.H. BaeS. The change of antibiotic susceptibility in febrile urinary tract infection in childhood and adolescence during the last decadeInvestig. Clin. Urol.2022639910610.4111/icu.20210350PMC875614634983128
  26. WadaK. YokoyamaT. UnoS. ArakiM. SadahiraT. MaruyamaY. AcostaH. NakajimaH. HiyamaY. KunishimaY. Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU)J. Infect. Chemother.2021271169118010.1016/j.jiac.2021.03.01233863634
  27. TerlizziM.E. GribaudoG. MaffeiM.E. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial StrategiesFront. Microbiol.20178156610.3389/fmicb.2017.0156628861072PMC5559502
  28. DhakalB.K. KulesusR.R. MulveyM.A. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coliEur. J. Clin. Investig.200838(Suppl. S2)21110.1111/j.1365-2362.2008.01986.x18616559
  29. KostakiotiM. HultgrenS.J. HadjifrangiskouM. Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeuticsVirulence2012359259410.4161/viru.2236423154288PMC3545937
  30. HadidiM.F. AlhamamiN. AlhakamiM. AbdulhamidA.S. AlsharifA. AlomariM.S. AlghamdiY.A. AlshehriS. GhaddafA.A. AlsenaniF.M. Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: A systematic review and network meta-analysisWorld J. Urol.20244222110.1007/s00345-024-04922-538587648
  31. JungC. BrubakerL. The etiology and management of recurrent urinary tract infections in postmenopausal womenClimacteric20192224224910.1080/13697137.2018.155187130624087PMC6629580
  32. CastanheiraM. SimnerP.J. BradfordP.A. Extended-spectrum beta-lactamases: An update on their characteristics, epidemiology and detectionJAC Antimicrob. Resist.20213dlab09210.1093/jacamr/dlab09234286272PMC8284625
  33. BaeS. Practice Pattern Survey I: Analysis Study on the Actual Clinical Practices for Cystitis Treatment2024 KUA Abstr.2024359EP-015Available online: https://www.urology.or.kr/abstract/2024_fall/file/KUA_2024_Abstract_book_241011_1.pdf?v=1(accessed on 5 November 2024)
  34. DellitT.H. OwensR.C. McGowanJ.E.Jr. GerdingD.N. WeinsteinR.A. BurkeJ.P. HuskinsW.C. PatersonD.L. FishmanN.O. CarpenterC.F. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardshipClin. Infect. Dis.20074415917710.1086/51039317173212
  35. SchutsE.C. HulscherM. MoutonJ.W. VerduinC.M. StuartJ. OverdiekH. van der LindenP.D. NatschS. HertoghC. WolfsT.F.W. Current evidence on hospital antimicrobial stewardship objectives: A systematic review and meta-analysisLancet Infect. Dis.20161684785610.1016/S1473-3099(16)00065-726947617
  36. HumphriesR.M. AbbottA.N. HindlerJ.A. Understanding and Addressing CLSI Breakpoint Revisions: A Primer for Clinical LaboratoriesJ. Clin. Microbiol.20195710-112810.1128/JCM.00203-19PMC653559530971460
  37. WeinsteinM.P. LewisJ.S.2nd The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and ProcessesJ. Clin. Microbiol.20205810-112810.1128/JCM.01864-19PMC704157631915289
  38. KahlmeterG. GiskeC.G. KirnT.J. SharpS.E. Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility ResultsJ. Clin. Microbiol.20195710-112810.1128/JCM.01129-19PMC671192231315957